Metformin + Glyburide Tablets
Formulated to target blood glucose, utilized to manage type 2 diabetes mellitus.
Strengths: 2.5/400 · 5/500mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Glucovance
- Therapeutic class
Biguanide and Sulphonylurea Combination
- Pharmacological class
Antidiabetic
- Contraindications
diabetic ketoacidosis; severe renal insufficiency
- Precautions and warnings
monitor blood glucose; risk of hypoglycaemia
- Minor side effects
nausea; diarrhoea
- Moderate side effects
hypoglycaemia; abdominal discomfort
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Patient summary
Formulated to target blood glucose, utilized to manage type 2 diabetes mellitus.
- Prescription status
POM
- Manufacturer
Merck
- Onset Time
1–2 hours
- Duration
12–24 hours
- Storage instructions
Store in a dry place below 25°C.
- Drug interactions
alcohol; corticosteroids
Serious side effects
lactic acidosis — requires immediate medical attention; severe hypoglycaemia — requires immediate medical attention
Mechanism of action
This combination provides dual therapy: metformin decreases hepatic glucose production and increases insulin sensitivity, while glibenclamide stimulates pancreatic insulin secretion from beta cells.
Pregnancy and breastfeeding
Pregnancy: Not recommended; insulin is preferred. Breastfeeding: Not recommended.
Metformin + Glyburide Tablets
Formulated to target blood glucose, utilized to manage type 2 diabetes mellitus.
Editorial Notes
- Active ingredient(s): Metformin, Glibenclamide
- Listed indication(s): Type 2 Diabetes Mellitus